anti-CD105 antibody product blog
Tags: Antibody; Monoclonal Antibody; CD105; anti-CD105 antibody;
The CD105 n/a (Catalog #MBS530002) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. The CD105 antibody (FITC) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s CD105 can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS), Immunohistochemistry (IHC).FC: 10 ug/ml. Researchers should empirically determine the suitability of the CD105 n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
Mouse monoclonal CD105 antibody (FITC).
Biological Significance: Human CD105 (endoglin) is a homodimeric membrane glycoprotein virtually restricted to endothelial cells, and present on some leukemia cells and minor subsets of bone marrow cells. CD105 binds to TGF-beta1 and beta3 with high affinity. Biohazard Information: This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
Tag/Conjugate: FITC
Immunogen: CD105 antibody (FITC) was raised in mouse using membrane preparation of human B-lineage leukemia cells as the immunogen. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing CD105 are readily searchable from our website. Different antibodies against the same target such as CD105 may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.